CDTI Innovación invests in CRB Digital Health III, a fund specialized in digital health investment

The Innvierte SICC (CDTI Innovación) invests in CRB Digital Health III, a fund specialized in digital health investment, focused on driving technological innovation and the transformation of the healthcare system.

With this commitment, CDTI Innovación reinforces its investment strategy in companies that leverage disruptive technologies to improve people’s well-being.

CRB Digital Health III, F.C.R.E., is the first European fund fully dedicated to digital health based in Spain. It is managed by CRB Health Tech SGEIC and focuses on investing in companies with a proven business model and clear growth opportunities. Its strategy is oriented towards the development of disruptive technologies applied to prevention, diagnosis, and treatment, as well as platforms that enhance the efficiency and sustainability of the healthcare system.

The entry of CDTI Innovación, through Innvierte, into this fund with a €10 million commitment strengthens institutional support for a strategy focused on developing innovative solutions in digital health, aiming to transform the healthcare system through innovation, technology, and long-term capital. The shared goal of this initiative is to position Spain as a leading digital health hub in Southern Europe, fostering the development of technologies that improve efficiency, clinical quality, and the sustainability of healthcare systems.

The backing of CDTI Innovación, through Innvierte, reinforces public-private collaboration in the digital health sector, with the commitment to improving people’s health.

CRB Health Tech

CRB Health Tech SGEIC is a venture capital management firm specialized in healthcare technologies, including biotechnology, medical devices, and digital health.

Founded in 2008 by a multidisciplinary team based in Madrid and Barcelona, it supports visionary entrepreneurs and innovative projects that are transforming the healthcare landscape through disruptive technologies.

The investment thesis of CRB Digital Health III focuses on the convergence of digital technologies and healthcare. It seeks opportunities spanning platforms that bridge gaps in healthcare access and efficiency, diagnostic solutions that improve accuracy, and treatment solutions that empower patients through digital interventions, achieving better clinical outcomes. By providing this strategic support, the firm aims to drive positive transformation in the healthcare sector.

Innvierte

Innvierte is an initiative aimed at promoting business innovation by supporting venture capital investment in technology-based or innovative companies. The program is structured through the closed-end collective investment scheme Innvierte Economía Sostenible SICC S.M.E., S.A., self-managed and supervised by the Spanish National Securities Market Commission (CNMV), with CDTI Innovación as its sole shareholder.

To date, CDTI Innovación has committed, through Innvierte, €3.4785 billion across 61 investment vehicles, and through its co-investment line has directly committed €866.1 million in 197 companies.

Innvierte is part of the Spanish Science, Technology and Innovation Strategy 2021–2027, which defines the objectives and measures to promote R&D+i and strengthen its impact on economic growth.

CDTI Innovación

The CDTI Innovación (Centre for the Development of Technology and Innovation) is the Spanish Ministry of Science, Innovation and Universities’ innovation agency, aimed at promoting technological innovation in the business sector.

Its mission is to ensure that Spain’s business ecosystem generates and transforms scientific and technical knowledge into globally competitive, sustainable, and inclusive growth. In 2025, under its 2024–2027 Strategic Plan, CDTI provided more than €2 billion in support to Spanish companies and startups.